Gene Therapy for ALS: progress and prospects.

Area of Science:

• Neuroscience
• Genetics
• Biotechnology

Background:

• Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease with no effective drug treatments.
• Gene therapy presents a potential strategy to slow or stop motor neuron loss in ALS.

Purpose of the Study:

• To review the potential of gene therapy using viral vectors for treating ALS.
• To discuss the features of lentiviral vectors and their application in motor neuron disease models.
• To outline the prospects for clinical translation of gene therapy for human ALS.

Main Methods:

• Review of current literature on gene therapy for motor neuron diseases.
• Focus on lentiviral vectors and adeno-associated viruses for gene transfer.
• Analysis of animal studies demonstrating gene correction in ALS models.

Main Results:

• Viral vectors like lentiviral vectors and adeno-associated virus enable long-term gene expression in neurons.
• Successful gene transfer and correction have been achieved in animal models of motor neuron disease.
• Vectors have been refined for safety and efficacy in preclinical settings.

Conclusions:

• Gene therapy, particularly with lentiviral vectors, holds significant promise for ALS treatment.
• Addressing key challenges is crucial for advancing viral vector-based gene therapy to clinical trials for ALS patients.
• Further research and development are needed to translate preclinical successes into effective human therapies.